AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
MedImmune reports results for first 6 months of 2002.(Brief Article)
2002 AUG 28 - (NewsRx.com & NewsRx.net) -- MedImmune, Inc., (MEDI) announced that total revenues for the first 6 months of 2002 increased 41% to $393 million from $279 million in the first 6 months of 2001.
Product sales grew 43% during the 2002 6-month period, primarily due to continuing strong sales of Synagis, which rose 38% to $326 million ($314 million in the U.S.) from $236 million ($220 million in the U.S.) in the first half of 2001.
Synagis is the company's flagship product used to prevent respiratory syncytial virus (RSV) in high- risk infants. RSV is most commonly active in the Northern Hemisphere from late September to early May.
MedImmune's revenues for the 2002 second quarter increased 91% to $64 million from $33 million in the second quarter of 2001. Driving the revenue growth for the 2002 quarter were increases in sales of Synagis to $32 million ($27 million in the U.S.) and Ethyol to $17 million ($16 million in the U.S.). In the 2001 second quarter, Synagis sales totaled $15 million ($8 million in the U.S.), while Ethyol contributed $3 million ($2 million in the U.S.).
"We are pleased with the performance of our business during the first half of 2002," stated David M. Mott, MedImmune's chief executive officer. "Synagis ended the ...
- Aviron Strengthens FluMist(TM) Commercial Infrastructure With Two Transactions...
- Press release article from: PR Newswire October 11, 2000 700+ words
...Calif., Oct. 11 /PRNewswire/ -- Aviron (Nasdaq: AVIR) today announced that its United Kingdom (UK) subsidiary, Aviron UK Ltd., has agreed to acquire a 25...approximately eight acres of land in Speke, UK. Aviron intends to utilize an existing 45,000...
- Aviron, CSL Limited Sign Agreement on Licensing and Distribution Of...
- Press release article from: PR Newswire June 22, 1998 700+ words
...Australia, June 22 /PRNewswire/ -- Aviron (Nasdaq: AVIR) of Mountain View, California...sale and distribution of FluMist(TM), Aviron's intranasal influenza vaccine, in...Pacific. Under the Agreement, CSL and Aviron will jointly carry out additional trials...
- Aviron Announces $15 Million in Private Financing
- Press release article from: PR Newswire April 1, 1997 700+ words
...studies sponsored by the NIH. Aviron expects pivotal efficacy results...the third quarter of 1997. Aviron closed the 1996 financial year...approximately $2 million per month will continue or increase somewhat...the remainder of the year. Aviron is an emerging biopharmaceutical...
- Aviron Receives Non-Filable Notification From FDA on FluMist;
- Press release article from: PR Newswire September 1, 1998 700+ words
...Leighton Read, M.D., Aviron's chairman and chief executive...for commercial production. "Aviron intends to discuss the need...it would take at least six months to conduct the trial and report...1999-2000 flu season." "Aviron is currently in late-stage...
- AVIRON BEGINS PHASE I/II CLINICAL TRIALS FOR NASAL SPRAY INFLUENZA VACCINE IN...
- Press release article from: PR Newswire November 13, 1995 700+ words
...Infectious Diseases (NIAID), Aviron is testing a trivalent (three...under contract to the NIAID. Aviron also announced today that it...people ranging in age from two months to more than 100 years and have...protective immune response. Aviron licensed this broad vaccine...
- Aviron Receives Small Business Innovation Research Grant for Development Of...
- Press release article from: PR Newswire August 4, 1998 700+ words
...Calif., Aug. 4 /PRNewswire/ -- Aviron (Nasdaq: AVIR) today announced the...The $750,000 grant is the second that Aviron has received for research on CMV. The...George Kemble, senior scientist at Aviron, the main goal is to select a single...
- Aviron Announces Initiation of Phase 2 Clinical Trial With Epstein-Barr Virus...
- Press release article from: PR Newswire October 25, 2000 700+ words
...Calif., Oct. 25 /PRNewswire/ -- Aviron (Nasdaq: AVIR) today announced the...a $1.5 million milestone payment to Aviron. No vaccine is currently available for...combines EBV vaccine technology developed by Aviron scientists with proprietary adjuvant technology...
- Aviron Adopts Shareholder Rights Plan
- Press release article from: PR Newswire October 8, 1997 700+ words
...Calif., Oct. 8 /PRNewswire/ -- Aviron (Nasdaq: AVIR) announced that its Board...Rights Plan is designed to enable all Aviron stockholders to realize the full value...unsolicited attempt is made to acquire Aviron. The adoption of the Rights Plan is intended...
Source: HighBeam Research, MedImmune reports results for first 6 months of 2002.(Brief Article)